20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T25214 | CCR-11 | CCR11,CCR 11 | Antibiotic |
CCR-11 is a tannin-containing derivative with antimicrobial activity. CCR-11 inhibits the proliferation of B. subtilis and HeLa cells. CCR-11 inhibits bacterial proliferation and bacterial cytoplasmic division by inhibit... | |||
T14688 | BMS CCR2 22 | CCR | |
BMS CCR2 22 is a potent and selective antagonist of CCR2 with calcium flux IC50 of 18 nM, chemotaxis IC50 of 1 nM, and binding IC50 of 5.1 nM. | |||
T10708 | CCR1 antagonist 6 | CCR | |
CCR1 antagonist 6 is a CCR1 antagonist (IC50: 3 nM). | |||
T10715 | CCR6 inhibitor 1 | CCR | |
CCR6 inhibitor 1 is an effective and selective inhibitor of CCR6 (IC50 of monkey and human CCR6 was 0.45 nM and 6 nM, respectively). CCR6 is associated with both autoimmune and non-autoimmune diseases, so CCR6 inhibitor ... | |||
T11481 | GSK2239633A | CCR | |
GSK2239633A is an allosteric antagonist of CC-chemokine receptor 4 (CCR4) with a pIC50 of 7.96 for the binding of [125I]-TARC to human CCR4. | |||
T10156 | CCR3 antagonist 1 | CCR | |
CCR3 antagonist 1 is a potent CCR3 antagonist, used for the research of inflammatory and immunologic diseases. | |||
T13114 | CCR2 antagonist 4 | Teijin compound 1 | CCR |
CCR2 antagonist 4 (Teijin compound 1) is a potent and specific antagonist of CCR2(IC50s of 180 nM), and potently inhibits MCP-1-induced chemotaxis(IC50 of 24 nM). | |||
TQ0103 | INCB3344 | CCR | |
INCB3344 is an effective, specific and orally bioavailable CCR2 antagonist with IC50 values of 9.5 nM (mCCR2) and 5.1 nM (hCCR2) in binding antagonism and 7.8 nM (mCCR2) and in 3.8 nM (hCCR2) antagonism of chemotaxis act... | |||
T4300 | AZD2098 | CCR | |
AZD2098 is a potent CC-chemokine receptor 4 (CCR4) inhibitor used for asthma research. | |||
TQ0283 | RS102895 | CCR | |
RS102895 is a potent CCR2 antagonist (IC50: 360 nM) and shows no effect on CCR1. | |||
T5384 | RS 504393 | CCR | |
RS 504393 is a highly selective CCR2 chemokine receptor antagonist (IC50s: 89 nM and > 100 μM for human recombinant CCR2 and CCR1). | |||
T14900 | CCR2-RA-[R] | CCR | |
CCR2-RA-[R] is a C-C chemokine receptor type 2 (CCR2) allosteric antagonist (IC50: 103 nM). | |||
T10712 | CCR2 antagonist 3 | AZD-2927,AZD2927 | CCR |
CCR2 antagonist 3 (AZD-2927) is an antagonist of CCR2. | |||
T4674 | SB297006 | SB 297006 | CCR |
SB297006 is an antagonist of C-C chemokine receptor 3 (CCR3; IC50 = 39 nM), which normally is activated by eotaxin, eotaxin-3, MCP-3, MCP-4, RANTES, and MIP-1δ. It is at least 250-fold selective for CCR3 over a panel of ... | |||
T24700 | R243 | R 243,R-243 | CCR |
R243 is CCR8 signaling and chemotaxis inhibitor. | |||
T10425 | AZ084 | CCR | |
AZ084 is a potent, selective, allosteric, and oral active CCR8 antagonist (Ki: 0.9 nM). It has the potential to treat asthma. | |||
T6413 | Bindarit | AF2838 | CCR |
Bindarit (AF2838) displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8. | |||
T16111 | ML604086 | CCR | |
ML604086 suppresses CCL1 mediated chemotaxis and enhances intracellular Ca2 concentrations. ML604086 is a selective inhibitor of CCR8. It also inhibiting CCL1 binding to CCR8 on circulating T-cells. | |||
T16091 | MK-0812 Succinate | Others , CCR | |
MK-0812 Succinate is an effective and selective CCR2 antagonist. It also has a high affinity at CCR2. | |||
T11699 | J-113863 | CCR | |
J-113863 is also a potent antagonist of the human CCR3 (IC50 of 0.58 nM) , but a weak antagonist of the mouse CCR3 (IC50 of 460 nM). J-113863 is inactive against CCR2, CCR4 and CCR5, as well as the LTB4 or TNF-α receptor... |